First Trust Advisors
AXSM icon

First Trust Advisors’s Axsome Therapeutics AXSM Stock Holding History

First Trust Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.6M Buy
577,479
+534,066
+1,230% +$92.2M 0.07% 357
2025
Q4 		$7.93M Buy
43,413
+6,276
+17% +$876K 0.01% 1198
2025
Q3 		$4.51M Sell
37,137
-25,023
-40% -$2.82M ﹤0.01% 1422
2025
Q2 		$6.49M Buy
62,160
+33,209
+115% +$3.52M 0.01% 1239
2025
Q1 		$3.38M Sell
28,951
-25,629
-47% -$2.92M ﹤0.01% 1521
2024
Q4 		$4.62M Buy
54,580
+11,488
+27% +$1.06M ﹤0.01% 1403
2024
Q3 		$3.87M Buy
43,092
+16,501
+62% +$1.44M ﹤0.01% 1459
2024
Q2 		$2.14M Sell
26,591
-38,921
-59% -$2.88M ﹤0.01% 1679
2024
Q1 		$5.23M Sell
65,512
-4,397
-6% -$369K 0.01% 1265
2023
Q4 		$5.56M Buy
+69,909
New +$4.67M 0.01% 1204

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors's AXSM Position: Q1 2026 in Review

First Trust Advisors increased its Axsome Therapeutics (AXSM) stake by 1,230% in Q1 2026, buying an estimated $92.2M and bringing the position to 577,479 shares worth $97.6M. The position accounts for 0.07% of the portfolio, ranked #357.

First Trust Advisors first reported a position in AXSM in Q4 2023 and has held it in 10 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • First Trust Advisors held 577,479 shares of Axsome Therapeutics worth $97.6M as of Q1 2026.
  • First Trust Advisors bought 534,066 Axsome Therapeutics shares in Q1 2026, an estimated $92.2M.
  • Axsome Therapeutics made up 0.07% of First Trust Advisors's portfolio in Q1 2026, its #357 holding.
  • First Trust Advisors first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.